Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial

Michiel S. van der Heijden*, Thomas Powles, Daniel Petrylak, Ronald de Wit, Andrea Necchi, Cora N. Sternberg, Nobuaki Matsubara, Hiroyuki Nishiyama, Daniel Castellano, Syed A. Hussain, Aristotelis Bamias, Georgios Gakis, Jae Lyun Lee, Scott T. Tagawa, Ulka Vaishampayan, Jeanny B. Aragon-Ching, Bernie J. Eigl, Rebecca R. Hozak, Erik R. Rasmussen, Meng Summer XiaRyan Rhodes, Sameera Wijayawardana, Katherine M. Bell-McGuinn, Amit Aggarwal, Alexandra Drakaki

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
19 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology